Premium
Tarsus Pharmaceuticals Inc (TARS)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-06-15 | Mr. Jeffrey S. FarrowCFO & Chief Strategy Officer | -14,40k | 877,44k | Derivative Exercise and Sale | 60,95 | 56,80k | - |
| 2026-06-15 | Mr. Jeffrey S. FarrowCFO & Chief Strategy Officer | 13,49k | 0,00 | Derivative Exercise and Retained Stock | - | 56,80k | 31,13% |
| 2026-06-15 | Dr. Katherine H. GoodrichIndependent Director | -2,95k | 183,38k | Automatic Disposition | 62,08 | 2,23k | -56,95% |
| 2026-06-15 | Dr. William J. LinkIndependent Director | -12,50k | 776,50k | Automatic Disposition | 61,97 - 62,94 | 106,79k | -10,48% |
| 2026-06-12 | Mr. Scott William MorrisonIndependent Director | 2,95k | 0,00 | Derivative Exercise and Retained Stock | - | 13,65k | 27,61% |
| 2026-06-12 | Dr. Katherine H. GoodrichIndependent Director | 2,95k | 0,00 | Derivative Exercise and Retained Stock | - | 5,19k | 132,29% |
| 2026-06-12 | Dr. Bhaskar ChaudhuriIndependent Director | 2,95k | 0,00 | Derivative Exercise and Retained Stock | - | 11,65k | 33,95% |
| 2026-06-12 | Dr. William J. LinkIndependent Director | 2,95k | 0,00 | Derivative Exercise and Retained Stock | - | 119,29k | 2,54% |
| 2026-06-12 | Ms. Wendy L. YarnoLead Independent Director | 2,95k | 0,00 | Derivative Exercise and Retained Stock | - | 16,65k | 21,56% |
| 2026-06-12 | Dr. Andrew D. GoldbergIndependent Director | 2,95k | 0,00 | Derivative Exercise and Retained Stock | - | 19,65k | 17,69% |
| 2026-04-24 | Dr. David E. I. PyottIndependent Director | 1,38k | 0,00 | Derivative Exercise and Retained Stock | - | 9,37k | 17,31% |
| 2026-03-20 | Dr. Seshadri NeervannanCOO | -2,99k | 199,52k | Automatic Disposition | 66,75 | 83,27k | -3,47% |
| 2026-03-17 | Dr. Seshadri NeervannanCOO | -11,32k | 772,44k | Vente | 67,00 - 69,42 | 86,26k | -11,60% |
| 2026-03-17 | Dr. Bryan WahlGeneral Counsel & Corporate Secretary | -12,44k | 850,42k | Vente | 67,00 - 69,42 | 63,96k | -16,28% |
| 2026-03-17 | Ms. Dianne C. WhitfieldChief HR Officer | -12,27k | 839,07k | Vente | 67,00 - 69,42 | 35,03k | -25,95% |
| 2026-03-17 | Dr. Bobak R. AzamianCo-Founder, President, CEO & Chairman | -34,60k | 2,36M | Vente | 67,00 - 69,42 | 891,41k | -3,74% |
| 2026-03-17 | Mr. Jeffrey S. FarrowCFO & Chief Strategy Officer | -6,43k | 439,57k | Vente | 67,00 - 69,42 | 43,32k | -12,93% |
| 2026-03-17 | Mr. Aziz MottiwalaChief Commercial Officer | -13,06k | 892,53k | Vente | 67,00 - 69,42 | 61,48k | -17,52% |
| 2026-03-17 | Dr. Elizabeth YeuChief Medical Officer | -1,14k | 78,20k | Vente | 67,00 - 69,42 | 41,71k | -2,67% |
| 2026-03-16 | Dr. William J. LinkIndependent Director | -12,50k | 859,82k | Automatic Disposition | 68,09 - 69,75 | 116,33k | -9,70% |
| 2026-03-15 | Ms. Dianne C. WhitfieldChief HR Officer | 23,91k | 0,00 | Derivative Exercise and Retained Stock | - | 47,30k | 102,21% |
| 2026-03-15 | Dr. Bryan WahlGeneral Counsel & Corporate Secretary | 24,24k | 0,00 | Derivative Exercise and Retained Stock | - | 76,40k | 46,46% |
| 2026-03-15 | Dr. Seshadri NeervannanCOO | 26,29k | 0,00 | Derivative Exercise and Retained Stock | - | 97,58k | 36,87% |
| 2026-03-15 | Mr. Aziz MottiwalaChief Commercial Officer | 26,48k | 0,00 | Derivative Exercise and Retained Stock | - | 74,54k | 55,11% |
| 2026-03-15 | Mr. Jeffrey S. FarrowCFO & Chief Strategy Officer | 13,04k | 0,00 | Derivative Exercise and Retained Stock | - | 49,75k | 35,53% |
| 2026-03-15 | Dr. Bobak R. AzamianCo-Founder, President, CEO & Chairman | 66,27k | 0,00 | Derivative Exercise and Retained Stock | - | 926,02k | 7,71% |
| 2026-03-15 | Dr. Elizabeth YeuChief Medical Officer | 2,51k | 0,00 | Derivative Exercise and Retained Stock | - | 42,85k | 6,22% |
| 2026-03-04 | Dr. Seshadri NeervannanCOO | -8,37k | 641,42k | Automatic Disposition | 76,67 | 71,29k | -10,50% |
| 2025-12-15 | Dr. Katherine H. GoodrichIndependent Director | 2,23k | 0,00 | Derivative Exercise and Retained Stock | - | 2,23k | - |
| 2026-01-02 | Ms. Dianne C. WhitfieldChief HR Officer | -15,57k | 1,26M | Automatic Disposition | 80,09 - 82,93 | 23,39k | -39,95% |
| 2025-12-24 | Dr. Bobak R. AzamianCo-Founder, President, CEO & Chairman | -6,00k | 495,09k | Automatic Disposition | 82,41 - 83,54 | 859,74k | -0,69% |
| 2025-12-16 | Ms. Dianne C. WhitfieldChief HR Officer | -7,40k | 592,50k | Automatic Disposition | 80,10 | 38,96k | -15,96% |
| 2025-12-16 | Dr. Seshadri NeervannanCOO | -950,00 | 0,00 | Other Disposition | - | 79,66k | -1,18% |
| 2025-12-15 | Dr. William J. LinkIndependent Director | -22,95k | 1,86M | Automatic Disposition | 80,71 - 82,39 | 128,83k | -15,12% |
| 2025-12-15 | Dr. Elizabeth YeuChief Medical Officer | 4,74k | 0,00 | Derivative Exercise and Retained Stock | - | 40,34k | 13,32% |
| 2025-12-15 | Dr. Elizabeth YeuChief Medical Officer | -2,08k | 165,20k | Derivative Exercise and Sale | 79,50 | 40,34k | - |
| 2025-12-04 | Dr. Bobak R. AzamianCo-Founder, President, CEO & Chairman | -51,89k | 0,00 | Other Disposition | - | 865,74k | -5,65% |
| 2025-09-24 | Dr. Bobak R. AzamianCo-Founder, President, CEO & Chairman | -6,00k | 332,22k | Automatic Disposition | 55,37 | 865,74k | -0,69% |
| 2025-09-16 | Dr. William J. LinkIndependent Director | -2,00k | 0,00 | Other Disposition | - | 151,78k | -1,30% |
| 2025-09-15 | Mr. Scott William MorrisonIndependent Director | 1,33k | 0,00 | Derivative Exercise and Retained Stock | - | 10,70k | 14,24% |
| 2025-09-08 | Dr. William J. LinkIndependent Director | -27,12k | 1,55M | Vente | 57,00 | 153,78k | -14,99% |
| 2025-08-11 | Dr. Bobak R. AzamianCo-Founder, President, CEO & Chairman | -6,00k | 300,00k | Automatic Disposition | 50,00 | 871,74k | -0,68% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
